(Q30988387)

16 October 2017

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC. (English)

1 reference

16 October 2017

1 reference

8

1 reference

16 October 2017

Yung-Ming Jeng

2

0 references

Po-huang Lee

object named as

Po-Huang Lee

7

0 references

author name string

Zhong-Zhe Lin

1

1 reference

16 October 2017

Fu-Chang Hu

3

1 reference

16 October 2017

Hung-Wei Pan

4

1 reference

16 October 2017

Hsin-Wei Tsao

5

1 reference

16 October 2017

Po-Lin Lai

6

1 reference

16 October 2017

Hey-Chi Hsu

9

1 reference

16 October 2017

language of work or name

English

0 references

publication date

28 August 2010

1 reference

16 October 2017

1 reference

16 October 2017

10

1 reference

16 October 2017

461

1 reference

The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Aurora kinases as anticancer drug targets

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Novel advancements in the management of hepatocellular carcinoma in 2008.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Aurora kinases as targets for cancer therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Targeting Aurora kinases for the treatment of prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Global cancer statistics, 2002

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Aurora-A - a guardian of poles

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Aurora-kinase inhibitors as anticancer agents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Overexpression and amplification of Aurora-A in hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Hepatocellular carcinoma: diagnosis and treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940801

Cancer epidemiology and control in Taiwan: a brief review

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Hepatocellular carcinoma: an epidemiologic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Genomic imbalances in Korean hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Chromosomal passengers: conducting cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Validating Aurora B as an anti-cancer drug target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Roles of Aurora kinases in mitosis and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-461

Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules

21 January 2018

1 reference

12 December 2020

Mutations of p53 gene in hepatocellular-carcinoma (hcc) correlate with tumor progression and patient prognosis - a study of 138 patients with unifocal hcc

1 reference

12 December 2020

Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness

1 reference

12 December 2020

Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy

1 reference

12 December 2020

Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-10-461

1 reference

Dimensions Publication ID

16 October 2017

0 references

1 reference

16 October 2017

PubMed publication ID

20799978

1 reference